Qualität

Eigenschaften

Molare Masse 1498.37 (PSMA I&T)

CAS RN [2192281-54-0] (PSMA I&T)

Reinheit ≥ 95 %

• White to off-white solid

Zertifikate

CoA: appearance, MS (identity), HPLC (purity), net peptide content (reported)

Literatur

Baum R.P. et al. ¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy. J. Nucl. Med. 2016, 57, 1006–1013.

Eiber M. et al. Systemic Radioligand Therapy with ¹⁷⁷Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer. J. Nucl. Med., 2016, 57(supplement 2): p. 61–61.

Schottelius M. et al. [¹¹¹In] PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res. 2015, 5, 68.